Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-12

Clinical Trial Update: POLARx Cardiac Cryoablation System Study

View source ↗

Summary

This update reports that the POLARx Cardiac Cryoablation System study by Boston Scientific for atrial fibrillation has completed and its results were posted on …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • POLARx Cardiac Cryoablation System

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Atrial Fibrillation | Status: COMPLETED | Results posted: 2024-02-12